Cargando…
Dyslipidemia in diffuse large B-cell lymphoma based on the genetic subtypes: a single-center study of 259 Chinese patients
BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) is a kind of highly heterogeneous non-Hodgkin lymphoma, both in clinical and genetic terms. DLBCL is admittedly categorized into six subtypes by genetics, which contain MCD, BN2, EZB, N1, ST2, and A53. Dyslipidemia is relevant to a multitude of solid...
Autores principales: | Xu, Yi, Shen, Huafei, Shi, Yuanfei, Zhao, Yanchun, Zhen, Xiaolong, Sun, Jianai, Li, Xueying, Zhou, De, Yang, Chunmei, Wang, Jinhan, Huang, Xianbo, Wei, Juying, Huang, Jian, Meng, Haitao, Yu, Wenjuan, Tong, Hongyan, Jin, Jie, Xie, Wanzhuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299728/ https://www.ncbi.nlm.nih.gov/pubmed/37384286 http://dx.doi.org/10.3389/fonc.2023.1172623 |
Ejemplares similares
-
The efficacy and cardiac toxicity of different‐dose pegylated liposomal doxorubicin in elderly patients with diffuse large B lymphoma
por: Li, Li, et al.
Publicado: (2022) -
m(6)A-binding proteins: the emerging crucial performers in epigenetics
por: Zhao, Yanchun, et al.
Publicado: (2020) -
Apatinib enhances chemosensitivity of ABT‐199 in diffuse large B‐cell lymphoma
por: Shi, Yuanfei, et al.
Publicado: (2022) -
The emerging roles of N6-methyladenosine RNA methylation in human cancers
por: Shen, Huafei, et al.
Publicado: (2020) -
Inhibition of VEGFR2 overcomes venetoclax-resistance in diffuse large B-cell lymphoma cells
por: Shi, Yuanfei, et al.
Publicado: (2022)